More and more evidence suggesting that the adenosine A2A receptor is a promising target for antiparkinson treatment. Adenosine A2A receptors…
More and more evidence suggesting that the adenosine A2A receptor is a promising target for antiparkinson treatment. Adenosine A2A receptors…